Biotechnology

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA Cites Drawbacks at Emergent BioSolutions Vaccine Plant

Rebecca Urena04/21/2021

54

On Wednesday, The Food and Drug Administration revealed that Emergent BioSolutions (NYSE: EBS) Baltimore plant, which manufactured Johnson and Johnson Covid-19 vaccines, was unsanitary and unsuitable to produce the...

Biotechnology Healthcare Investing News Market News Medical Use Pharmaceutical Products The Market Buzz

Johnson & Johnson Reports Q1 Earnings Topping Consensus Forecast

Rebecca Urena04/20/2021

73

Johnson & Johnson (NYSE: JNJ) reported USD100 Million in first-quarter sales from its Covid-19 vaccine on Tuesday. The company topped the consensus forecast and upped its 2021 earnings forecast....

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Regeneron Set to Request FDA Approval to Use Covid Antibody Drug as a Preventative Treatment

Rebecca Urena04/12/2021

143

Regeneron Pharmaceuticals (NASDAQ: REGN) announced Monday that it is prepared to ask the Food and Drug Administration for approval to use its Covid-19 antibody therapy as a preventative treatment....

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

179

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Biotechnology Breaking News Cannabis Buzz Healthcare Market News Medical Use Pharmaceutical Products Recreational Use The Market Buzz

Breaking News: Pure Extracts Submits Dealer’s Licence Application to Health Canada

financial buzz03/04/2021

204

Pure Extracts Technologies Corp. (OTC: PRXTF) (CSE: PULL) (XFRA: A2QJAJ)(“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic...

Biotechnology Breaking News Buzz on The Street Healthcare Investing News Market News Technology The Market Buzz

“Buzz on the Street” Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Export of Psilocybin

financial buzz03/01/202103/03/2021

74

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

financial buzz03/01/2021

132

Mydecine Innovations Group (OTC: MYCOF) (CSE: MYCO) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, production,...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

financial buzz02/11/2021

188

MindMed (OTCQB: MMEDF) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic...

Biotechnology Breaking News Buzz on The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

financial buzz02/11/202102/11/2021

40

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz

AstraZeneca Vaccine Suspended in South Africa

Rebecca Urena02/08/2021

348

AstraZeneca (OTCMKTS: AZNCF), Swedish drugmaker’s, Covid-19 vaccine proved to be as little as 10% effective against South Africa’s new coronavirus variant, according to a study. The country has now...

FDA Cites Drawbacks at Emergent BioSolutions Vaccine Plant

Johnson & Johnson Reports Q1 Earnings Topping Consensus Forecast

Regeneron Set to Request FDA Approval to Use Covid Antibody Drug as a Preventative Treatment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Breaking News: Pure Extracts Submits Dealer’s Licence Application to Health Canada

“Buzz on the Street” Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Export of Psilocybin

Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Breaking News: MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

“Buzz on the Street” Show: Algernon Pharmaceuticals (OTCQB: AGNPF) (CSE: AGN) Lung Scarring Study

AstraZeneca Vaccine Suspended in South Africa

The Buzz Surrounding First Responder Technologies Inc.

Entertainment One and Alibaba Pictures Announce Joint Production to Bring Peppa Pig to Theaters in China

Environmental Class Action Plaintiffs Achieve Major Victory in Federal Appeals Court

SpaceX Set to Launch Mission with Reused Rocket

Chipotle Reports Earnings, Topping Estimates

“Buzz on the Street” Show: Tevano Systems Holdings (CSE: TEVO) Health Shield for Workplace Safety

Latest Tweets